Viking Therapeutics, Inc. (VKTX)
Viking Therapeutics, Inc. (VKTX) is a Healthcare stock tracked by StreetAlpha. VKTX reports earnings on Wed, Oct 28, 2026. Analyst consensus is Strong Buy, based on the latest ratings from 3 firms (3 buy, 0 hold, 0 sell). Over the past 90 days StreetAlpha recorded 1 whale options trade in VKTX, 0% of them bullish and 100% bearish. In the past 30 days there were 3 dark pool prints.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Oct 7 | Truist Securities | Target lowered | Buy | — |
| Sep 23 | Truist Securities | Maintained | Buy | — |
| Aug 11 | JP Morgan | Maintained | Buy | — |
| Jul 30 | Canaccord Genuity | Maintained | Buy | — |
| May 28 | Lake Street | Initiated | Buy | — |
Whale Options Flow
90DDark Pool
30DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether VKTX is in one of them and how their past VKTX trades turned out.
VKTX News Tone and Price
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered VKTX in an article yet. Here's the latest on the wider market.